Toll-Free Screening, Advice Service Would Enchance OTC Mevacor - Merck
This article was originally published in The Tan Sheet
Executive Summary
Merck would support an OTC version of its statin drug Mevacor with an ambitious customer education program that would ensure proper usage of the cholesterol-lowering medication, the firm stated July 13 at a joint meeting of FDA's Nonprescription and Endocrinologic & Metabolic Drugs Advisory Committees.
You may also be interested in...
Mevacor OTC Study Shows Cholesterol-Lowering Consistent With Rx Statins
A cholesterol self-management program for OTC Mevacor was effective in deterring consumers from improperly purchasing the nonprescription version of the cholesterol-lowering drug, results from the CUSTOM actual-use study show
Mevacor OTC Study Shows Cholesterol-Lowering Consistent With Rx Statins
A cholesterol self-management program for OTC Mevacor was effective in deterring consumers from improperly purchasing the nonprescription version of the cholesterol-lowering drug, results from the CUSTOM actual-use study show
Mevacor OTC Study Shows Cholesterol-Lowering Consistent With Rx Statins
A cholesterol self-management program for OTC Mevacor was effective in deterring consumers from improperly purchasing the nonprescription version of the cholesterol-lowering drug, results from the CUSTOM actual-use study show